Rejji Kuruvilla
Papers
1
Total Citations
100
H-Index
1
About
Rejji Kuruvilla is a pioneering researcher at the intersection of chemical biology and regenerative medicine, whose work has fundamentally advanced the use of zebrafish as a platform for high-throughput in vivo drug discovery. His most notable contribution is the development of automated reporter-based high-throughput screening (HTS) in zebrafish, a breakthrough that enables whole-organism chemical screens at scales previously only possible in vitro. This innovation, detailed in his highly cited 2015 paper (100 citations), directly addresses a critical bottleneck in drug discovery by allowing researchers to identify novel pathways for increasing pancreatic β-cell mass—a key goal for diabetes therapy. By demonstrating that complex vertebrate biology can be harnessed for large-scale pharmacological interrogation, Kuruvilla has opened new avenues for identifying therapeutic compounds with greater physiological relevance. His work exemplifies how integrating advanced imaging, automation, and zebrafish genetics can accelerate the translation of basic biological insights into potential treatments, making him a leading figure in the quest for regenerative therapies for metabolic diseases.
Research Focus
Key Achievements
Top Papers
- 1